Rheumatoid Arthritis: Insights into Appropriate Diagnosis, Treatment and Management
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Immunology".
Deadline for manuscript submissions: 20 February 2026 | Viewed by 37
Special Issue Editor
Special Issue Information
Dear Colleagues,
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by synovitis that leads to bone destruction and functional disability. Although treatment for RA has advanced dramatically with the widespread use of the treat-to-target strategy and the development of targeted molecular therapies, some patients still face significant challenges. Some patients find it difficult to achieve treatment goals, a condition known as difficult-to-treat RA. Furthermore, an ageing society is leading to an increase in late-onset RA and older RA patients with multiple comorbidities. Further improvements in RA management require precision medicine to ensure appropriate treatment at an early stage and address various non-RA issues patients have.
The aim of this Special Issue is to provide new insights into the diagnosis, treatment and management of RA. We welcome original research papers, reviews, and meta-analyses that will contribute to improving clinical practice for RA patients and enhance their quality of life.
Dr. Satoshi Takanashi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- rheumatoid arthritis
- precision medicine
- difficult-to-treat rheumatoid arthritis
- late-onset rheumatoid arthritis
- ageing society
- comorbidities
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
